Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott W Lee

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Diabetes Technology & Therapeutics|July 13, 2017
Accuracy of a Fourth-Generation Subcutaneous Continuous Glucose SensorMark P Christiansen, Satish K Garg, Ronald Brazg, et al.
The New England Journal of Medicine|June 25, 2013
Threshold-based insulin-pump interruption for reduction of hypoglycemiaRichard M Bergenstal, David C Klonoff, Satish K Garg, et al.
Pediatric Diabetes|January 10, 2022
Glycemic outcomes of children 2-6 years of age with type 1 diabetes during the pediatric MiniMed™ 670G system trialGregory P Forlenza, Laya Ekhlaspour, Linda A DiMeglio, et al.
Diabetes Technology & Therapeutics|August 14, 2023
Safety Event Outcomes and Glycemic Control with a Hybrid Closed-Loop System Used by Chinese Adolescents and Adults with Type 1 Diabetes MellitusYu Pei, Weijian Ke, Jing Lu, et al.
Diabetes Technology & Therapeutics|December 27, 2018
Safety Evaluation of the MiniMed 670G System in Children 7-13 Years of Age with Type 1 DiabetesGregory P Forlenza, Orit Pinhas-Hamiel, David R Liljenquist, et al.
Diabetes Technology & Therapeutics|August 1, 2018
Accuracy of a Fourth-Generation Continuous Glucose Monitoring System in Children and Adolescents with Type 1 DiabetesRobert H Slover, Jeanie B Tryggestad, Linda A DiMeglio, et al.
Diabetes Technology & Therapeutics|October 10, 2018
In-Clinic Evaluation of the MiniMed 670G System "Suspend Before Low" Feature in Children with Type 1 DiabetesMichael A Wood, Dorothy I Shulman, Gregory P Forlenza, et al.
Diabetes Technology & Therapeutics|January 31, 2017
Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 DiabetesSatish K Garg, Stuart A Weinzimer, William V Tamborlane, et al.
Diabetes Technology & Therapeutics|May 30, 2023
Glycemic Outcomes During Early Use of the MiniMed™ 780G Advanced Hybrid Closed-Loop System with Guardian™ 4 SensorToni L Cordero, Zheng Dai, Arcelia Arrieta, et al.
Diabetes Technology & Therapeutics|March 9, 2022
Evaluation of Extended Infusion Set Performance in Adults with Type 1 Diabetes: Infusion Set Survival Rate and Glycemic Outcomes from a Pivotal TrialRon Brazg, Satish K Garg, Anuj Bhargava, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Diabetes Technology & Therapeutics|July 13, 2017
Accuracy of a Fourth-Generation Subcutaneous Continuous Glucose SensorMark P Christiansen, Satish K Garg, Ronald Brazg, et al.
The New England Journal of Medicine|June 25, 2013
Threshold-based insulin-pump interruption for reduction of hypoglycemiaRichard M Bergenstal, David C Klonoff, Satish K Garg, et al.
Pediatric Diabetes|January 10, 2022
Glycemic outcomes of children 2-6 years of age with type 1 diabetes during the pediatric MiniMed™ 670G system trialGregory P Forlenza, Laya Ekhlaspour, Linda A DiMeglio, et al.
Diabetes Technology & Therapeutics|August 14, 2023
Safety Event Outcomes and Glycemic Control with a Hybrid Closed-Loop System Used by Chinese Adolescents and Adults with Type 1 Diabetes MellitusYu Pei, Weijian Ke, Jing Lu, et al.
Diabetes Technology & Therapeutics|December 27, 2018
Safety Evaluation of the MiniMed 670G System in Children 7-13 Years of Age with Type 1 DiabetesGregory P Forlenza, Orit Pinhas-Hamiel, David R Liljenquist, et al.
Diabetes Technology & Therapeutics|August 1, 2018
Accuracy of a Fourth-Generation Continuous Glucose Monitoring System in Children and Adolescents with Type 1 DiabetesRobert H Slover, Jeanie B Tryggestad, Linda A DiMeglio, et al.
Diabetes Technology & Therapeutics|October 10, 2018
In-Clinic Evaluation of the MiniMed 670G System "Suspend Before Low" Feature in Children with Type 1 DiabetesMichael A Wood, Dorothy I Shulman, Gregory P Forlenza, et al.
Diabetes Technology & Therapeutics|January 31, 2017
Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 DiabetesSatish K Garg, Stuart A Weinzimer, William V Tamborlane, et al.
Diabetes Technology & Therapeutics|May 30, 2023
Glycemic Outcomes During Early Use of the MiniMed™ 780G Advanced Hybrid Closed-Loop System with Guardian™ 4 SensorToni L Cordero, Zheng Dai, Arcelia Arrieta, et al.
Diabetes Technology & Therapeutics|March 9, 2022
Evaluation of Extended Infusion Set Performance in Adults with Type 1 Diabetes: Infusion Set Survival Rate and Glycemic Outcomes from a Pivotal TrialRon Brazg, Satish K Garg, Anuj Bhargava, et al.
Pageof 4